We are happy to be part of the collaborative work between the European Medicines Agency (EMA), industry experts, academia, and DHTs developers, on the evolving regulatory perspectives on digital health technologies for medicinal product development.

The article presents multi-stakeholder views on regulatory challenges and potential solutions brought by DHTs like the Syde® wearable device in medicines development.

Follow the link to read the article